PSI CRO

We are a leading full-service global Contract Research Organization (CRO) with a key strength in predictable patient enrollment across multiple therapeutic areas. Since our founding in 1995 by Dr. Robert Reekie and Dr. Roger A. Smith, we've been dedicated to revolutionizing how clinical trials are conducted, focusing on delivering high-quality, cost-effective solutions worldwide. Our mission is to be the best CRO in the world as measured by our employees, clients, investigative sites, and vendors. This commitment is reflected in our exceptionally high repeat and referral business rates and minimal staff turnover.

Our global reach allows us to conduct clinical trials across multiple continents and in over 50 countries. We are known in the industry for our 'on-time project delivery,' a reputation we've built by investing substantial effort and medical expertise into performing quality feasibility assessments that provide accurate predictors of study timelines. In fact, over 90% of our studies finish on time or ahead of schedule. We specialize in planning and executing global pivotal registration clinical trials, particularly in complex areas like oncology, hematology, infectious diseases, gastroenterology, multiple sclerosis, and rare indications. We embrace innovation and technology, leveraging cutting-edge methodologies and data-driven insights to optimize trial design, streamline operations, and enhance patient engagement. Our robust quality management systems and adherence to the highest industry standards, including ISO 9001:2015 and ISO 27001:2013 certifications, underscore our dedication to excellence. We are proud of our contributions to advancing healthcare by helping bring life-saving therapies and treatments to market. We actively engage in research collaborations and knowledge sharing to contribute to scientific advancement.